Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Feng

Showing results (1121-1130 of 2,038) with videos related to

Pageof 204
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 25, 2019
[The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways]Y Feng, M Y Zhou, F Sun, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 13, 2019
Randomized Controlled Trials in Functional Neurosurgery-Association of Device Approval Status and Trial QualityTej D Azad, Austin Y Feng, Swapnil Mehta, et al.
Advances in Radiation Oncology|July 18, 2022
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialKevin Shee, Claire M de la Calle, Albert J Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02Alan Pollack, James J Dignam, Dayssy A Diaz, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural ChinaH-Q Pan, S Bele, Y Feng, et al.
European Review for Medical and Pharmacological Sciences|December 16, 2017
Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancerL-P Zhao, R-H Li, D-M Han, et al.
Brachytherapy|May 14, 2017
External beam radiation therapy with or without low-dose-rate brachytherapy: Analysis of favorable and unfavorable intermediate-risk prostate cancer patientsAhmed E Abugharib, Robert T Dess, Payal D Soni, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Cancer Research|November 6, 2021
Loss of Long Noncoding RNA <i>NXTAR</i> in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide ResistanceRuchi Ghildiyal, Mithila Sawant, Arun Renganathan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2001
Cholangiohepatitis and inflammatory bowel disease induced by a novel urease-negative Helicobacter species in A/J and Tac:ICR:HascidfRF miceN H Shomer, C A Dangler, M D Schrenzel, et al.
Pageof 204

Showing results (1121-1130 of 2,038) with videos related to

Sort By:
Pageof 204
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 25, 2019
[The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways]Y Feng, M Y Zhou, F Sun, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 13, 2019
Randomized Controlled Trials in Functional Neurosurgery-Association of Device Approval Status and Trial QualityTej D Azad, Austin Y Feng, Swapnil Mehta, et al.
Advances in Radiation Oncology|July 18, 2022
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialKevin Shee, Claire M de la Calle, Albert J Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02Alan Pollack, James J Dignam, Dayssy A Diaz, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural ChinaH-Q Pan, S Bele, Y Feng, et al.
European Review for Medical and Pharmacological Sciences|December 16, 2017
Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancerL-P Zhao, R-H Li, D-M Han, et al.
Brachytherapy|May 14, 2017
External beam radiation therapy with or without low-dose-rate brachytherapy: Analysis of favorable and unfavorable intermediate-risk prostate cancer patientsAhmed E Abugharib, Robert T Dess, Payal D Soni, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Cancer Research|November 6, 2021
Loss of Long Noncoding RNA <i>NXTAR</i> in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide ResistanceRuchi Ghildiyal, Mithila Sawant, Arun Renganathan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2001
Cholangiohepatitis and inflammatory bowel disease induced by a novel urease-negative Helicobacter species in A/J and Tac:ICR:HascidfRF miceN H Shomer, C A Dangler, M D Schrenzel, et al.
Pageof 204